MEDP:NGS-Medpace Holdings Inc. (USD)

EQUITY | Diagnostics & Research | Nasdaq Global Select

Last Closing

USD 376.26

Change

+4.26 (+1.15)%

Market Cap

USD 1.47B

Volume

0.36M

Analyst Target

USD 118.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-22 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

+7.78 (+1.66%)

USD 41.47B
ICLR ICON PLC

-0.54 (-0.18%)

USD 25.49B
ILMN Illumina Inc

-0.69 (-0.55%)

USD 19.47B
NTRA Natera Inc

-0.43 (-0.46%)

USD 11.20B
EXAS EXACT Sciences Corporation

+0.53 (+0.88%)

USD 10.68B
RDNT RadNet Inc

+1.21 (+2.40%)

USD 3.57B
SHC Sotera Health Co

-0.36 (-3.19%)

USD 3.10B
OLK Olink Holding AB ADR

+0.34 (+1.50%)

USD 2.72B
NEOG Neogen Corporation

+0.20 (+1.63%)

USD 2.63B
GH Guardant Health Inc

+0.32 (+1.75%)

USD 1.96B

ETFs Containing MEDP

AJEUAS:SW UBS (Irl) Fund Solutions .. 96.30 % 0.00 %

+2.42 (+0.45%)

N/A
S6EW:SW Ossiam STOXX® Europe 600.. 4.65 % 0.00 %

N/A

USD 0.12B
PTH Invesco DWA Healthcare Mo.. 4.61 % 0.60 %

+0.55 (+0.45%)

USD 0.13B
AMID Argent Mid Cap ETF 3.44 % 0.00 %

+0.18 (+0.45%)

USD 0.06B
STUX:SW SPDR® MSCI Europe Utilit.. 3.06 % 0.00 %

+0.70 (+0.45%)

USD 0.16B
JSMD Janus Henderson Small/Mid.. 2.98 % 0.50 %

+0.36 (+0.45%)

USD 0.34B
INRE:PA iShares Global Clean Ener.. 2.69 % 0.00 %

+0.08 (+0.45%)

N/A
INRG:SW iShares Global Clean Ener.. 2.62 % 0.00 %

+0.08 (+0.45%)

USD 3.09B
HEAL:SW iShares Healthcare Innova.. 1.69 % 0.00 %

+0.09 (+0.45%)

N/A
QSML:AU VanEck MSCI International.. 1.23 % 0.00 %

-0.21 (0.45%)

USD 0.60B
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

N/A

CAD 0.01B
RFG Invesco S&P MidCap 400® .. 0.00 % 0.35 %

+0.65 (+0.45%)

USD 0.33B
PSC Principal U.S. Small-Cap .. 0.00 % 0.38 %

+0.38 (+0.45%)

USD 0.51B
XMHQ Invesco S&P MidCap Qualit.. 0.00 % 0.25 %

+1.20 (+0.45%)

USD 4.66B
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+6.25 (+0.45%)

USD 1.14B
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

+0.09 (+0.45%)

USD 1.14B
INRG:LSE iShares Global Clean Ener.. 0.00 % 0.00 %

+7.75 (+0.45%)

USD 3.20B
L6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

+91.00 (+0.45%)

USD 0.24B
LCPE:LSE Ossiam Shiller Barclays C.. 0.00 % 0.00 %

+227.50 (+0.45%)

USD 0.16B
S6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

+0.94 (+0.45%)

USD 0.35M
JELS:LSE 0.00 % 0.00 %

N/A

N/A
UTIL:LSE SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

+1.90 (+0.45%)

USD 0.10B
S6EW:PA Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

+0.12 (+0.45%)

USD 0.12B
STU:PA SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

+1.82 (+0.45%)

USD 0.11B
IQQH:F iShares Global Clean Ener.. 0.00 % 0.00 %

+0.07 (+0.45%)

USD 3.09B
OSX6:F Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.00 %

+0.44 (+0.45%)

USD 0.12B
SPYU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+2.04 (+0.45%)

USD 0.11B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

+0.06 (+0.45%)

USD 1.14B
DXSH:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

N/A

USD 0.03B
IQQH:XETRA iShares Global Clean Ener.. 0.00 % 0.00 %

+0.05 (+0.45%)

USD 3.34B
OSX6:XETRA Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

-0.34 (0.45%)

USD 0.16B
SPYU:XETRA SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

+1.66 (+0.45%)

USD 0.16B
IBBJ 0.00 % 0.00 %

N/A

N/A
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

+0.07 (+0.45%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.75% 89% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.75% 89% A- 85% B
Trailing 12 Months  
Capital Gain 100.93% 95% A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.93% 95% A 95% A
Trailing 5 Years  
Capital Gain 558.14% 100% F 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 558.14% 100% F 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 44.01% 82% B 89% A-
Dividend Return 44.01% 82% B 89% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.65% 68% D+ 46% F
Risk Adjusted Return 113.88% 100% F 99% N/A
Market Capitalization 1.47B 94% A 94% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 128.40 37% 22%
Price/Book Ratio 22.76 6% 5%
Price / Cash Flow Ratio 29.01 10% 10%
Price/Free Cash Flow Ratio 34.75 8% 7%
Management Effectiveness  
Return on Equity 59.83% 98% 98%
Return on Invested Capital 57.06% 100% 96%
Return on Assets 13.99% 98% 98%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.